The startup, which prescribes weight-loss drugs like Ozempic and Wegovy in combination with coaching, is planning to restructure its business as part of the sale, according to the Slack message, those people said. In a statement to Insider, a Calibrate spokesperson said the company announced a “legal restructuring,” with new financial commitments from Madryn Asset Management and other previous investors.
Read the full article: Weight-Loss Startup Calibrate Is Selling Itself to a Private Equity Firm as Patient Complaints Mount //
Source: https://www.businessinsider.com/weight-loss-startup-calibrate-sells-to-madryn-asset-management-2023-10